Recovery Centers of America-owned subsidiary, Genetworx Labs, performs COVID-19 testing and was featured in an April 24, 2020 Washington Post article for its diagnostic expertise. In the Washington Post article, CEO William Miller explains that, unlike most labs, Genetworx is equipped as a molecular testing laboratory and diagnosing coronavirus involves a more difficult molecular test. Because of Genetworx’ specialized instrumentation and expertise, the Lab is able to perform accurate COVID-19 testing at increasingly large volumes during the pandemic, according to Miller.
Read the entire Washington Post article: The Health 202: Here’s why the U.S. can’t get its coronavirus testing act together
